Skip to contentSkip to filters

We use cookies for analytics.

Topic: endocannabinoid system

Seminar
1 seminar

In Biochemistry and Biology

Seminar · Neuropharmacology

Targeting the Endocannabinoid System for Management of Chemotherapy, HIV and Antiretroviral-Induced Neuropathic Pain

Willias Masocha · Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Kuwait University, Kuwait

Thu, Sep 24, 2020 · 15:00 UTC

Chemotherapeutic drugs (used for treating cancer), HIV infection and antiretroviral therapy (ART) can independently cause difficult-to-manage painful neuropathy. Paclitaxel, a chemotherapeutic drug, for example is associated with high incidence of peripheral neuropathy, around 71% of the patients of which 27% of these develop neuropathic pain. Use of cannabis or phytocannabinoids has been reported to improve pain measures in patients with neuropathic pain, including painful HIV-associated sensory neuropathy and cancer pain. Phytocannabinoids and endocannabinoids, such as anandamide and 2-arach